Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2016

Feb 10, 2016

31523_dirs_2016-02-10_d8fbdcb0-6ae5-4e50-98f9-2edb94ecd07e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-02-08

Reporting Person: Rosenberg Ellen (General Counsel & Corp. Secy)